spl_product_data_elements stringlengths 15 26.7k | description stringlengths 1 18.3k ⌀ | indications_and_usage stringlengths 1 29.7k ⌀ | contraindications stringlengths 5 20.2k ⌀ | warnings stringlengths 1 46.9k ⌀ | precautions stringlengths 3 45.6k ⌀ | general_precautions stringlengths 7 21.7k ⌀ | drug_interactions stringlengths 1 38.4k ⌀ | pregnancy stringlengths 10 13.1k ⌀ | pediatric_use stringlengths 14 12.7k ⌀ | adverse_reactions stringlengths 1 85.9k ⌀ | overdosage stringlengths 12 16.1k ⌀ | dosage_and_administration stringlengths 1 56.1k ⌀ | how_supplied stringlengths 10 16.4k ⌀ | id stringlengths 36 36 | dosage_forms_and_strengths stringlengths 3 4.92k ⌀ | warnings_and_cautions stringlengths 11 75.6k ⌀ | information_for_patients stringlengths 16 33.5k ⌀ | storage_and_handling stringlengths 1 37.5k ⌀ | active_ingredient stringlengths 1 3.59k ⌀ | purpose stringlengths 1 3.32k ⌀ | keep_out_of_reach_of_children stringlengths 1 2.25k ⌀ | inactive_ingredient stringlengths 1 5.81k ⌀ | do_not_use stringlengths 1 1.73k ⌀ | ask_doctor stringlengths 6 1.41k ⌀ | when_using stringlengths 1 3.05k ⌀ | stop_use stringlengths 1 2.28k ⌀ | brand_name stringlengths 2 841 ⌀ | generic_name stringlengths 3 512 ⌀ | manufacturer_name stringlengths 3 79 ⌀ | product_type stringclasses 3
values | route stringclasses 59
values | substance_name stringlengths 3 2.56k ⌀ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Nifedipine Nifedipine NIFEDIPINE NIFEDIPINE GLYCERIN PEPPERMINT POLYETHYLENE GLYCOL 400 SACCHARIN SODIUM AMMONIA GELATIN, UNSPECIFIED FERROSOFERRIC OXIDE LIGHT MINERAL OIL METHYLPARABEN PROPYLENE GLYCOL PROPYLPARABEN SHELLAC SORBITOL TITANIUM DIOXIDE WATER HP194 | Nifedipine, USP is an antianginal drug belonging to a class of pharmacological agents, the calcium channel blockers. Nifedipine is 1, 4-Dihydro-2, 6-dimethyl-4-(2-nitrophenyl)-3, 5-pyridinecarboxylic acid dimethyl ester, C 17 H 18 N 2 O 6 , and has the structural formula: Nifedipine, USP is a yellow crystalline substan... | I. Vasospastic Angina Nifedipine is indicated for the management of vasospastic angina confirmed by any of the following criteria: 1) classical pattern of angina at rest accompanied by ST segment elevation, 2) angina or coronary artery spasm provoked by ergonovine, or 3) angiographically demonstrated coronary artery sp... | Known hypersensitivity reaction to nifedipine. | Excessive Hypotension Although, in most patients, the hypotensive effect of nifedipine is modest and well tolerated, occasional patients have had excessive and poorly tolerated hypotension. These responses have usually occurred during initial titration or at the time of subsequent upward dosage adjustment. Although pat... | General: Hypotension: Because nifedipine decreases peripheral vascular resistance, careful monitoring of blood pressure during the initial administration and titration of nifedipine is suggested. Close observation is especially recommended for patients already taking medications that are known to lower blood pressure. ... | General: Hypotension: Because nifedipine decreases peripheral vascular resistance, careful monitoring of blood pressure during the initial administration and titration of nifedipine is suggested. Close observation is especially recommended for patients already taking medications that are known to lower blood pressure. ... | Beta-adrenergic blocking agents: (See INDICATIONS AND USAGE and WARNINGS . ) Experience in over 1,400 patients in a non-comparative clinical trial has shown that concomitant administration of nifedipine and beta-blocking agents is usually well tolerated, but there have been occasional literature reports suggesting that... | Category C: Nifedipine has been shown to produce teratogenic findings in rats and rabbits, including digital anomalies similar to those reported for phenytoin. Digital anomalies have been reported to occur with other members of the dihydropyridine class and are possibly a result of compromised uterine blood flow. Nifed... | Safety and effectiveness in pediatric patients have not been established. Use in pediatric population is not recommended. | In multiple-dose United States and foreign controlled studies in which adverse reactions were reported spontaneously, adverse effects were frequent but generally not serious and rarely required discontinuation of therapy or dosage adjustment. Most were expected consequences of the vasodilator effects of nifedipine. Adv... | Experience with nifedipine overdosage is limited. Generally, overdosage with nifedipine leading to pronounced hypotension calls for active cardiovascular support including monitoring of cardiovascular and respiratory function, elevation of extremities, and judicious use of calcium infusion, pressor agents, and fluids. ... | The dosage of nifedipine needed to suppress angina and that can be tolerated by the patient must be established by titration. Excessive doses can result in hypotension. Therapy should be initiated with the 10 mg capsule. The starting dose is one 10 mg capsule, swallowed whole, 3 times/day. The usual effective dose rang... | Nifedipine Capsules, USP are available as white opaque, oblong soft gelatin capsules containing 10 mg of nifedipine. Each capsule is imprinted with " HP 194" in black ink. They are supplied as follows: Cartons of 100 soft gelatin capsules (10 soft gelatin capsules each blister pack x 10), NDC 0904-7229-61 WARNING: This... | ec34e627-67f0-4151-a214-5151d54a7c26 | null | null | null | null | null | null | null | null | null | null | null | null | Nifedipine | NIFEDIPINE | Major Pharmaceuticals | HUMAN PRESCRIPTION DRUG | ORAL | NIFEDIPINE |
Irbesartan and Hydrochlorothiazide Irbesartan and Hydrochlorothiazide IRBESARTAN IRBESARTAN HYDROCHLOROTHIAZIDE HYDROCHLOROTHIAZIDE CARBOXYMETHYLCELLULOSE CALCIUM SILICON DIOXIDE POVIDONE K29/32 SODIUM STARCH GLYCOLATE TYPE A POTATO TALC MAGNESIUM STEARATE HYPROMELLOSE 2910 (15 MPA.S) TITANIUM DIOXIDE POLYETHYLENE GLYC... | Irbesartan and hydrochlorothiazide tablets USP are a combination of an angiotensin II receptor antagonist (AT 1 subtype), irbesartan, and a thiazide diuretic, hydrochlorothiazide (HCTZ). Irbesartan USP is a non-peptide compound, chemically described as a 2-butyl-3-[p-(o-1H-tetrazol-5-ylphenyl)benzyl]-1,3-diazaspiro[4.4... | Irbesartan and hydrochlorothiazide tablets are indicated for the treatment of hypertension. Irbesartan and hydrochlorothiazide tablets may be used in patients whose blood pressure is not adequately controlled on monotherapy. Irbesartan and hydrochlorothiazide tablets may also be used as initial therapy in patients who ... | Irbesartan and hydrochlorothiazide tablets are contraindicated in patients who are hypersensitive to any component of this product. Because of the hydrochlorothiazide component, this product is contraindicated in patients with anuria or hypersensitivity to other sulfonamide-derived drugs. Do not coadminister aliskiren ... | null | null | null | • NSAIDs and selective COX-2 inhibitors: Can reduce diuretic, natriuretic of diuretic, may lead to increased risk of renal impairment and reduced antihypertensive effect. Monitor renal function periodically. ( 7 ) • Dual blockade of the renin-angiotensin system: Increased risk of renal impairment, hypotension, and hype... | Risk Summary Irbesartan and hydrochlorothiazide tablets can cause fetal harm when administered to a pregnant woman. Use of drugs that act on the renin-angiotensin system during the second and third trimesters of pregnancy reduces fetal renal function and increases fetal and neonatal morbidity and death [see Clinical Co... | Safety and effectiveness in pediatric patients have not been established. | • Most common adverse events (≥5% on irbesartan and hydrochlorothiazide tablets and more often than on placebo) are dizziness, fatigue, and musculoskeletal pain. ( 6.1 ) To report SUSPECTED ADVERSE REACTIONS, contact Macleods Pharma USA, Inc. at 1-888-943-3210 or 1-855-926-3384 or FDA at 1-800-FDA-1088 or www.fda.gov/m... | Irbesartan No data are available in regard to overdosage in humans. However, daily doses of 900 mg for 8 weeks were well tolerated. The most likely manifestations of overdosage are expected to be hypotension and tachycardia; bradycardia might also occur from overdose. Irbesartan is not removed by hemodialysis. To obtai... | General Considerations • Maximum effects within 2 to 4 weeks after dose change. ( 2.1 ) • Renal impairment: Not recommended for patients with severe renal impairment (creatinine clearance <30 mL/min). ( 2.1 , 5.8 ) Hypertension • Initiate with 150/12.5 mg. Titrate to 300/12.5 mg then 300/25 mg if needed. ( 2.2 ) • Repl... | /STORAGE AND HANDLING 16.1 How Supplied Irbesartan and hydrochlorothiazide film-coated tablets USP have markings on one side and are available in the strengths and packages listed in the following table: Tablet Strength (irbesartan and hydrochlorothiazide) Film-Coated Tablet Color/Shape Tablet Markings Package Size NDC... | f2ef667a-4871-4f28-a0b3-3f79fbbe180c | Irbesartan and hydrochlorothiazide 150/12.5 mg and 300/12.5 mg film-coated tablets are peach and oval with ML 34 and ML 33 debossed on one side respectively, and plain on the reverse side. • 150 mg irbesartan/12.5 mg hydrochlorothiazide tablets ( 3 ) • 300 mg irbesartan/12.5 mg hydrochlorothiazide tablets ( 3 ) | 5 WARNINGS AND PRECAUTIONS Hypotension: Correct volume depletion prior to administration. ( 5.2 ) Impaired renal function. ( 5.7 ) Thiazide diuretics may cause an exacerbation or activation of systemic lupus erythematosus. ( 5.4 ) Acute angle-closure glaucoma, acute myopia, and choroidal effusion. ( 5.8 ) 5.1 Fetal Tox... | 17 PATIENT COUNSELING INFORMATION Pregnancy Tell female patients of childbearing age about the consequences of exposure to irbesartan and hydrochlorothiazide tablets during pregnancy. Discuss treatment options with women planning to become pregnant. Ask patients to report pregnancies to their physician as soon as possi... | null | null | null | null | null | null | null | null | null | Irbesartan and Hydrochlorothiazide | IRBESARTAN AND HYDROCHLOROTHIAZIDE | Macleods Pharmaceuticals Limited | HUMAN PRESCRIPTION DRUG | ORAL | HYDROCHLOROTHIAZIDE, IRBESARTAN |
LISINOPRIL and HYDROCHLOROTHIAZIDE LISINOPRIL and HYDROCHLOROTHIAZIDE LISINOPRIL LISINOPRIL ANHYDROUS HYDROCHLOROTHIAZIDE HYDROCHLOROTHIAZIDE ANHYDROUS LACTOSE CROSCARMELLOSE SODIUM MAGNESIUM STEARATE FERRIC OXIDE RED FERRIC OXIDE YELLOW oval shaped, mottled C;71 LISINOPRIL and HYDROCHLOROTHIAZIDE LISINOPRIL and HYDROC... | Lisinopril and Hydrochlorothiazide Tablets combines an angiotensin converting enzyme inhibitor, lisinopril, and a diuretic, hydrochlorothiazide. Lisinopril, a synthetic peptide derivative, is an oral long-acting angiotensin converting enzyme inhibitor. It is chemically described as (S)-1-[ N2 -(1-carboxy-3-phenylpropyl... | Lisinopril and Hydrochlorothiazide Tablets are indicated for the treatment of hypertension, to lower blood pressure. Lowering blood pressure lowers the risk of fatal and non-fatal cardiovascular events, primarily strokes and myocardial infarctions. These benefits have been seen in controlled trials of antihypertensive ... | Lisinopril and Hydrochlorothiazide Tablets are contraindicated in patients who are hypersensitive to this product and in patients with a history of angioedema related to previous treatment with an angiotensin converting enzyme inhibitor and in patients with hereditary or idiopathic angioedema. Because of the hydrochlor... | Lisinopril Anaphylactoid and Possibly Related Reactions: Presumably because angiotensin-converting enzyme inhibitors affect the metabolism of eicosanoids and polypeptides, including endogenous bradykinin, patients receiving ACE inhibitors (including Lisinopril and Hydrochlorothiazide Tablets) may be subject to a variet... | General Lisinopril Aortic Stenosis/Hypertrophic Cardiomyopathy: As with all vasodilators, lisinopril should be given with caution to patients with obstruction in the outflow tract of the left ventricle. Impaired Renal Function: As a consequence of inhibiting the renin-angiotensin-aldosterone system, changes in renal fu... | General Lisinopril Aortic Stenosis/Hypertrophic Cardiomyopathy: As with all vasodilators, lisinopril should be given with caution to patients with obstruction in the outflow tract of the left ventricle. Impaired Renal Function: As a consequence of inhibiting the renin-angiotensin-aldosterone system, changes in renal fu... | Lisinopril Hypotension - Patients on Diuretic Therapy: Patients on diuretics, and especially those in whom diuretic therapy was recently instituted, may occasionally experience an excessive reduction of blood pressure after initiation of therapy with lisinopril. The possibility of hypotensive effects with lisinopril ca... | null | Neonates with a history of in utero exposure to Lisinopril and Hydrochlorothiazide Tablets If oliguria or hypotension occurs, direct attention toward support of blood pressure and renal perfusion. Exchange transfusions or dialysis may be required as a means of reversing hypotension and/or substituting for disordered re... | Lisinopril and Hydrochlorothiazide Tablets have been evaluated for safety in 930 patients, including 100 patients treated for 50 weeks or more. In clinical trials with Lisinopril and Hydrochlorothiazide Tablets no adverse experiences peculiar to this combination drug have been observed. Adverse experiences that have oc... | No specific information is available on the treatment of overdosage with Lisinopril and Hydrochlorothiazide Tablets. Treatment is symptomatic and supportive. Therapy with Lisinopril and Hydrochlorothiazide Tablets should be discontinued and the patient observed closely. Suggested measures include induction of emesis an... | Lisinopril monotherapy is an effective treatment of hypertension in once-daily doses of 10 mg to 80 mg, while hydrochlorothiazide monotherapy is effective in doses of 12.5 mg per day to 50 mg per day. In clinical trials of lisinopril/hydrochlorothiazide combination therapy using lisinopril doses of 10 mg to 80 mg and h... | Lisinopril and Hydrochlorothiazide Tablets,USP 10 mg/12.5 mg: Pink colored, oval shaped, mottled, unscored tablets, debossed with “C71” on one side and plain on other side. They are available as follows: NDC- 51407-564-90 bottles of 90 tablets NDC- 51407-564-05 bottles of 500 tablets Lisinopril and Hydrochlorothiazide ... | fd91c3d4-99e0-4b5d-8f6c-d08f19b64703 | null | null | Angioedema: Angioedema, including laryngeal edema, may occur at any time during treatment with angiotensin converting enzyme inhibitors, including lisinopril and hydrochlorothiazide tablets. Patients should be so advised and told to report immediately any signs or symptoms suggesting angioedema (swelling of face, extre... | null | null | null | null | null | null | null | null | null | LISINOPRIL and HYDROCHLOROTHIAZIDE | LISINOPRIL AND HYDROCHLOROTHIAZIDE | GSMS, Incorporated | HUMAN PRESCRIPTION DRUG | ORAL | HYDROCHLOROTHIAZIDE, LISINOPRIL |
"ARTHROTEC diclofenac sodium and misoprostol DICLOFENAC SODIUM DICLOFENAC MISOPROSTOL MISOPROSTOL SI(...TRUNCATED) | "ARTHROTEC is a combination product containing diclofenac sodium, an NSAID with analgesic properties(...TRUNCATED) | "ARTHROTEC is indicated for treatment of the signs and symptoms of osteoarthritis or rheumatoid arth(...TRUNCATED) | "ARTHROTEC is contraindicated in the following patients: • Pregnancy. Use of misoprostol, a compon(...TRUNCATED) | null | null | null | "See Table 1 for clinically significant drug interactions with diclofenac and misoprostol. Table 1: (...TRUNCATED) | "Risk Summary ARTHROTEC is contraindicated in pregnant women [see Contraindications (4) ]. If a woma(...TRUNCATED) | Safety and effectiveness of ARTHROTEC in pediatric patients have not been established. | "The following adverse reactions are discussed in greater detail in other sections of the labeling: (...TRUNCATED) | "Manage patients with symptomatic and supportive care following an acute NSAID overdosage. There are(...TRUNCATED) | "• Use the lowest effective dosage for the shortest duration consistent with individual patient tr(...TRUNCATED) | "/STORAGE AND HANDLING ARTHROTEC (diclofenac sodium and misoprostol delayed-release tablets) are sup(...TRUNCATED) | 2b1bf1d7-4399-46bd-8654-2590513da5c2 | "Delayed-release tablets: • 50 mg diclofenac sodium and 200 mcg misoprostol as round, biconvex, wh(...TRUNCATED) | "5 WARNINGS AND PRECAUTIONS • Embryo-Fetal Toxicity with NSAIDs : Use of NSAIDs, including diclofe(...TRUNCATED) | "17 PATIENT COUNSELING INFORMATION Advise the patient to read the FDA-approved patient labeling (Med(...TRUNCATED) | "Store at 20°C to 25°C (68°F to 77°F). Excursions permitted to 15°C to 30°C (59°F to 86°F) [(...TRUNCATED) | null | null | null | null | null | null | null | null | ARTHROTEC | DICLOFENAC SODIUM AND MISOPROSTOL | Pfizer Laboratories Div Pfizer Inc | HUMAN PRESCRIPTION DRUG | ORAL | DICLOFENAC SODIUM, MISOPROSTOL |
"Ursodiol Ursodiol URSODIOL URSODIOL MEDIUM-CHAIN TRIGLYCERIDES COPOVIDONE K25-31 HYPROMELLOSE, UNSP(...TRUNCATED) | "Ursodiol Tablets, USP 250 mg are available as a film-coated tablet for oral administration. Ursodio(...TRUNCATED) | "Ursodiol tablets are indicated for the treatment of patients with primary biliary cholangitis (PBC)(...TRUNCATED) | "Patients with complete biliary obstruction and known hypersensitivity or intolerance to ursodiol or(...TRUNCATED) | null | null | null | "• Bile Acid Sequestering Agents : May interfere with the action of ursodiol by reducing its absor(...TRUNCATED) | "Risk Summary Available published data on the use of ursodiol in pregnant women derived from randomi(...TRUNCATED) | The safety and effectiveness of ursodiol in pediatric patients have not been established. | "Most common adverse reactions reported with the use of ursodiol during worldwide postmarketing and (...TRUNCATED) | "There have been no reports of accidental or intentional overdosage with ursodiol. Single oral doses(...TRUNCATED) | "• Recommended adult dosage : 13 to 15 mg/kg/day administered in two to four divided doses with fo(...TRUNCATED) | "/STORAGE AND HANDLING 16.1 Ursodiol Tablet, USP 250 mg The 250 mg dosage form is a white to off-whi(...TRUNCATED) | 322b164b-3399-4863-abd6-489173169b7c | "• Ursodiol tablets, USP 250 mg • Ursodiol tablets, USP 500 mg scored tablet • Ursodiol tablet(...TRUNCATED) | "5 WARNINGS AND PRECAUTIONS • Abnormal Liver Function Tests : Liver function tests (γ-GT, alkalin(...TRUNCATED) | "17 PATIENT COUNSELING INFORMATION Enteroliths in Patients with Risk for Intestinal Stenosis or Stas(...TRUNCATED) | null | null | null | null | null | null | null | null | null | Ursodiol | URSODIOL | Major Pharmaceuticals | HUMAN PRESCRIPTION DRUG | ORAL | URSODIOL |
"Carbidopa and Levodopa Carbidopa and Levodopa Carbidopa Carbidopa Anhydrous Levodopa Levodopa Magne(...TRUNCATED) | "Carbidopa and levodopa tablets are a combination product for the treatment of Parkinson's disease a(...TRUNCATED) | "Carbidopa and levodopa tablets, USP are indicated in the treatment of Parkinson's disease, post-enc(...TRUNCATED) | "Nonselective monoamine oxidase (MAO) inhibitors are contraindicated for use with carbidopa and levo(...TRUNCATED) | "When carbidopa and levodopa tablets are to be given to patients who are being treated with levodopa(...TRUNCATED) | "General As with levodopa, periodic evaluations of hepatic, hematopoietic, cardiovascular, and renal(...TRUNCATED) | "General As with levodopa, periodic evaluations of hepatic, hematopoietic, cardiovascular, and renal(...TRUNCATED) | "Caution should be exercised when the following drugs are administered concomitantly with carbidopa (...TRUNCATED) | "No teratogenic effects were observed in a study in mice receiving up to 20 times the maximum recomm(...TRUNCATED) | "Safety and effectiveness in pediatric patients have not been established. Use of the drug in patien(...TRUNCATED) | "The most common adverse reactions reported with carbidopa and levodopa tablets have included dyskin(...TRUNCATED) | "Management of acute overdosage with carbidopa and levodopa tablets is the same as management of acu(...TRUNCATED) | "The optimum daily dosage of carbidopa and levodopa tablets must be determined by careful titration (...TRUNCATED) | "Carbidopa and Levodopa Tablets, USP are supplied as follows: 10 mg/100 mg — Each mottled blue, ro(...TRUNCATED) | 3f6116d8-a60c-f7fe-c73c-b6ed1361b67f | null | null | "The patient should be informed that carbidopa and levodopa tablets are an immediate-release formula(...TRUNCATED) | "Store at 25°C (77°F); excursions permitted to 15°-30°C (59°-86°F) [see USP Controlled Room Te(...TRUNCATED) | null | null | null | null | null | null | null | null | Carbidopa and Levodopa | CARBIDOPA AND LEVODOPA | Dr. Reddy's Laboratories Inc | HUMAN PRESCRIPTION DRUG | ORAL | CARBIDOPA, LEVODOPA |
"ampicillin sodium and sulbactam sodium ampicillin sodium and sulbactam sodium AMPICILLIN SODIUM AMP(...TRUNCATED) | "Ampicillin and sulbactam for injection, USP is a sterile antibacterial fixed-combination drug produ(...TRUNCATED) | "Ampicillin and sulbactam for injection is indicated for the treatment of infections due to suscepti(...TRUNCATED) | "The use of ampicillin and sulbactam is contraindicated in individuals with a history of serious hyp(...TRUNCATED) | "Hypersensitivity Serious and occasionally fatal hypersensitivity (anaphylactic) reactions have been(...TRUNCATED) | "General: A high percentage of patients with mononucleosis who receive ampicillin develop a skin ras(...TRUNCATED) | null | null | "Reproduction studies have been performed in mice, rats, and rabbits at doses up to ten (10) times t(...TRUNCATED) | null | "Adult Patients: Ampicillin and sulbactam is generally well tolerated. The following adverse reactio(...TRUNCATED) | "Neurological adverse reactions, including convulsions, may occur with the attainment of high CSF le(...TRUNCATED) | "Ampicillin and sulbactam for injection may be administered by either the IV or the IM routes. For I(...TRUNCATED) | "Ampicillin and sulbactam for injection, USP is supplied as a sterile white to off-white dry powder (...TRUNCATED) | 44180e69-5422-2235-e063-6394a90aae5d | null | null | null | null | null | null | null | null | null | null | null | null | ampicillin sodium and sulbactam sodium | AMPICILLIN SODIUM AND SULBACTAM SODIUM | ONESOURCE SPECIALTY PHARMA LIMITED | HUMAN PRESCRIPTION DRUG | INTRAMUSCULAR, INTRAVENOUS | AMPICILLIN SODIUM, SULBACTAM SODIUM |
"OLMESARTAN MEDOXOMIL, AMLODIPINE and HYDROCHLOROTHIAZIDE Olmesartan Medoxomil, Amlodipine besylate (...TRUNCATED) | "Olmesartan medoxomil, amlodipine and hydrochlorothiazide provided as a tablet for oral administrati(...TRUNCATED) | "Olmesartan medoxomil, amlodipine and hydrochlorothiazide tablet is indicated for the treatment of h(...TRUNCATED) | "Because of the hydrochlorothiazide component, olmesartan medoxomil, amlodipine and hydrochlorothiaz(...TRUNCATED) | null | null | null | "Olmesartan medoxomil ( 7.1 ): Nonsteroidal anti-inflammatory drugs (NSAIDS): May lead to increased (...TRUNCATED) | "Risk Summary Olmesartan medoxomil, amlodipine and hydrochlorothiazide can cause fetal harm when adm(...TRUNCATED) | "The safety and effectiveness of olmesartan medoxomil, amlodipine and hydrochlorothiazide in pediatr(...TRUNCATED) | "Most common adverse reactions (incidence ≥2%) are dizziness, peripheral edema, headache, fatigue,(...TRUNCATED) | "There is no information on overdosage with olmesartan medoxomil, amlodipine and hydrochlorothiazide(...TRUNCATED) | "Dose once daily. Dosage may be increased in 2-week intervals, as needed. The maximum recommended do(...TRUNCATED) | "/STORAGE AND HANDLING Olmesartan medoxomil, amlodipine and hydrochlorothiazide tablets contain olme(...TRUNCATED) | 44b62ded-18e8-b2e8-e063-6294a90ac180 | "Olmesartan medoxomil, amlodipine and hydrochlorothiazide tablets are available in the following str(...TRUNCATED) | "5 WARNINGS AND PRECAUTIONS Hypotension: Correct volume or salt depletion prior to administration. ((...TRUNCATED) | "17 PATIENT COUNSELING INFORMATION Pregnancy: Tell female patients of childbearing age about the con(...TRUNCATED) | null | null | null | null | null | null | null | null | null | OLMESARTAN MEDOXOMIL, AMLODIPINE and HYDROCHLOROTHIAZIDE | OLMESARTAN MEDOXOMIL, AMLODIPINE BESYLATE AND HYDROCHLOROTHIAZIDE | Micro Labs Limited | HUMAN PRESCRIPTION DRUG | ORAL | AMLODIPINE BESYLATE, HYDROCHLOROTHIAZIDE, OLMESARTAN MEDOXOMIL |
"Sun Bum Protecting Scalp and Hair Mist SPF 30 sunscreen AVOBENZONE, HOMOSALATE, OCTISALATE, OCTOCRY(...TRUNCATED) | null | "Uses • helps prevent sunburn • if used as directed with other sun protection measures, (see Dir(...TRUNCATED) | null | "For external use only Flammable: do not use near hear, flame, or while smoking Do not use on damage(...TRUNCATED) | null | null | null | null | null | null | null | "Directions • shake well before use • hold container 4 to 6 inches from the skin to apply • sp(...TRUNCATED) | null | 3c3218d5-794b-c0a8-e063-6294a90a177a | null | null | null | null | s Octocrylene 4.00% Octisalate 5.00% Homosalate 10.00% Avobenzone 3.00% | Sunscreen | Warnings K eep Out Of Reach Of Children | "s alcohol denat. (70.10%), acrylates/octylacrylamide copolymer, polyester-8, butyloctyl salicylate,(...TRUNCATED) | null | null | null | null | "Sun Bum Protecting Scalp and Hair Mist SPF 30 sunscreen, Sun Bum Protecting Scalp and Hair Mist SPF(...TRUNCATED) | AVOBENZONE, HOMOSALATE, OCTISALATE, OCTOCRYLENE | Sun Bum, LLC | HUMAN OTC DRUG | TOPICAL | AVOBENZONE, HOMOSALATE, OCTISALATE, OCTOCRYLENE |
"Tylenol Sinus Severe, CVP HEALTH Acetaminophen, Guaifenesin, and Phenylephrine Hydrochloride CARNAU(...TRUNCATED) | null | "Uses temporarily relieves these symptoms associated with hay fever or other respiratory allergies, (...TRUNCATED) | null | "Liver warning This product contains acetaminophen. The maximum daily dose of this product is 10 cap(...TRUNCATED) | null | null | null | null | null | null | null | "Directions do not take more than directed (see overdose warning ) adults and children 12 years and (...TRUNCATED) | null | 459f7dbe-5021-08d1-e063-6294a90a8924 | null | null | null | "Other information each caplet contains: sodium 3 mg store between 20-25°C (68-77°F) do not use if(...TRUNCATED) | "s (in each caplet) Purpose Acetaminophen 325 mg Pain reliever/fever reducer Guaifenesin 200 mg Expe(...TRUNCATED) | "Active ingredients (in each caplet) Purpose Acetaminophen 325 mg Pain reliever/fever reducer Guaife(...TRUNCATED) | . | "s carnauba wax, croscarmellose sodium, flavor, hydroxypropyl cellulose, hypromellose, magnesium ste(...TRUNCATED) | "with any other drug containing acetaminophen (prescription or nonprescription). If you are not sure(...TRUNCATED) | "Ask a doctor before use if you have liver disease heart disease high blood pressure thyroid disease(...TRUNCATED) | this product do not exceed recommended dose | "and ask a doctor if nervousness, dizziness, or sleeplessness occur pain, nasal congestion or cough (...TRUNCATED) | "Tylenol Sinus Severe, Lil Drug Store, Tylenol Sinus Severe, CVP HEALTH, Tylenol Sinus Severe, TRAVE(...TRUNCATED) | ACETAMINOPHEN, GUAIFENESIN, AND PHENYLEPHRINE HYDROCHLORIDE | Lil Drug Store Products, Inc | HUMAN OTC DRUG | ORAL | ACETAMINOPHEN, GUAIFENESIN, PHENYLEPHRINE HYDROCHLORIDE |
End of preview. Expand in Data Studio
README.md exists but content is empty.
- Downloads last month
- 50